Vertical transmission of SARS-CoV-2 infection in early pregnancy: what is the evidence?
- 17 September 2020
- journal article
- letter
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (18) , 3512-3513
Abstract
(2020). Vertical transmission of SARS-CoV-2 infection in early pregnancy: what is the evidence?. The Journal of Maternal-Fetal & Neonatal Medicine. Ahead of Print.Keywords
This publication has 9 references indexed in Scilit:
- Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?eLife, 2020
- The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualizationbioRxiv, 2020
- Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 InfectionJAMA, 2020
- Placental Pathology in COVID-19American Journal of Clinical Pathology, 2020
- The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome studyPLOS ONE, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Structural basis of receptor recognition by SARS-CoV-2Nature, 2020
- Single-Cell RNA Expression Profiling of ACE2 and AXL in the Human Maternal-Fetal InterfaceReproductive and Developmental Medicine, 2020
- The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluationPathology, 2006